Frontiers in Psychiatry (Feb 2019)

Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes

  • Natalia de M. Lyra e Silva,
  • Minh P. Lam,
  • Claudio N. Soares,
  • Claudio N. Soares,
  • Douglas P. Munoz,
  • Roumen Milev,
  • Roumen Milev,
  • Fernanda G. De Felice,
  • Fernanda G. De Felice,
  • Fernanda G. De Felice

DOI
https://doi.org/10.3389/fpsyt.2019.00057
Journal volume & issue
Vol. 10

Abstract

Read online

Neuropsychiatric disorders and type 2 diabetes (T2D) are major public health concerns proposed to be intimately connected. T2D is associated with increased risk of dementia, neuropsychiatric and mood disorders. Evidences of the involvement of insulin signaling on brain mechanisms related to depression indicate that insulin resistance, a hallmark of type 2 diabetes, could develop in the brains of depressive patients. In this article, we briefly review possible molecular mechanisms associating defective brain insulin signaling with reward system, neurogenesis, synaptic plasticity and hypothalamic-pituitary-adrenal (HPA) stress axis in depression. We further discuss the involvement of tumor necrosis factor α (TNFα) promoting defective insulin signaling and depressive-like behavior in rodent models. Finally, due to the high resistant rate of anti-depressants, novel insights into the link between insulin resistance and depression may advance the development of alternative treatments for this disease.

Keywords